PROCEPT BioRobotics Forecast, price target & analysts
PROCEPT BioRobotics Target price 2025 - Analyst rating & recommendation
PROCEPT BioRobotics Classifications & Recommendation:
PROCEPT BioRobotics Price Target
| Target Price | $94.67 |
| Price | $65.02 |
| Potential |
45.60%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target PROCEPT BioRobotics 2026 .
The average PROCEPT BioRobotics target price is $94.67.
This is
45.60%
register free of charge
$105.00
61.49%
register free of charge
$77.00
18.43%
register free of charge
|
|
| A rating was issued by 11 analysts: 9 Analysts recommend PROCEPT BioRobotics to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the PROCEPT BioRobotics stock has an average upside potential 2026 of
45.60%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 224.50 | 321.96 |
| 64.84% | 43.41% | |
| EBITDA Margin | -40.70% | -12.06% |
| 47.39% | 70.37% |
11 Analysts have issued a sales forecast PROCEPT BioRobotics 2025 . The average PROCEPT BioRobotics sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an PROCEPT BioRobotics EBITDA forecast 2025. The average PROCEPT BioRobotics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.75 | -1.49 |
| 21.88% | 14.86% | |
| P/E | negative | |
| EV/Sales | 10.20 |
5 Analysts have issued a PROCEPT BioRobotics forecast for earnings per share. The average PROCEPT BioRobotics <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the PROCEPT BioRobotics stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
PROCEPT BioRobotics...
Current PROCEPT BioRobotics Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities | Locked ➜ Locked | Locked | Feb 26 2025 |
| Morgan Stanley | Locked ➜ Locked | Locked | Feb 26 2025 |
| Wells Fargo | Locked ➜ Locked | Locked | Dec 03 2024 |
| Morgan Stanley | Locked ➜ Locked | Locked | Dec 02 2024 |
| Jefferies | Locked ➜ Locked | Locked | Nov 14 2024 |
| Truist Securities | Locked ➜ Locked | Locked | Oct 30 2024 |
| Piper Sandler | Locked ➜ Locked | Locked | Oct 08 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities: Locked ➜ Locked
|
Feb 26 2025 |
|
Locked
Morgan Stanley: Locked ➜ Locked
|
Feb 26 2025 |
|
Locked
Wells Fargo: Locked ➜ Locked
|
Dec 03 2024 |
|
Locked
Morgan Stanley: Locked ➜ Locked
|
Dec 02 2024 |
|
Locked
Jefferies: Locked ➜ Locked
|
Nov 14 2024 |
|
Locked
Truist Securities: Locked ➜ Locked
|
Oct 30 2024 |
|
Locked
Piper Sandler: Locked ➜ Locked
|
Oct 08 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
